MNPR MONOPAR THERAPEUTICS US FDA Inspections 8-K Filing 2024 - Clinical Trial Update Monopar Therapeutics announced the successful dosing of the first patient in its Phase 1 clinical trial for the imaging radiopharmaceutical MNPR-101-Zr.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS